Literature DB >> 6873126

Different estimates of the risk of calcium oxalate crystallization in urine.

H G Tiselius.   

Abstract

Different mathematical expressions of urinary calcium, oxalate, magnesium, citrate and urine volume (V), formulated in order to reflect supersaturation with respect to calcium oxalate, were compared with the computer-calculated ion-activity product of calcium oxalate (APCaOx). A good correlation (r = 0.99) was demonstrated for the following two simplified relationships and APCaOx:Ca0.71 X Ox and (Ca0.71 X Ox)/V1.2. The correspondence between Ca/Mg quotients and APCaOx was generally less satisfactory.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6873126     DOI： 10.1159/000474089

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


  6 in total

1.  Can a relationship reflect the risk of calcium oxalate urolithiasis?

Authors:  P Roca; A Conte; T Riera; F Grases
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 2.  Clinical investigations.

Authors:  F Hering
Journal:  Urol Res       Date:  1990

Review 3.  Risk formulas in calcium oxalate urolithiasis.

Authors:  H G Tiselius
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?

Authors:  A L Rodgers; D Webber; B Hibberd
Journal:  Urolithiasis       Date:  2015-07-22       Impact factor: 3.436

5.  Assessment of crystallization risk formulas in pediatric calcium stone-formers.

Authors:  Przemysław Sikora; Małgorzata Zajaczkowska; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2009-03-31       Impact factor: 3.714

Review 6.  Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders.

Authors:  Norbert Laube; Wolfgang Berg; Falk Bernsmann; Sascha Gravius; Florian Klein; Stefan Latz; Dirk von Mallek; Tadeusz Porowski; Thomas Randau; Anna Wasilewska; Christian Fisang
Journal:  EPMA J       Date:  2014-08-16       Impact factor: 6.543
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.